As 2024 draws to a close, the new year ushers in the opportunity to set new goals for the year ahead. While weight-loss and fitness are staples of New Year resolutions they are commonly known to be the unsustainable resolutions that don’t continue past January.
Cybin Completes Enrollment in Phase 2 Study of CYB003 in Major Depressive Disorder | Psychedelic Invest
–Phase 2 topline efficacy data for CYB003 on track for Q4 2023, followed by U.S. Food and Drug Administration (“FDA”) submission of CYB003 Phase 1/2
September 21, 2023